CD37 is a tetraspannin that triggers cell death and is a potential therapeutic target in cancers. In this issue of Cancer Cell, Lapalombella et al. show that CD37 is tyrosine phosphorylated following engagement by a bivalent engineered antibody fragment that binds CD37 and activates both SHP-1-dependent apoptotic signaling and PI3K-AKT-mediated survival signaling
Cutaneous T-cell lymphomas (CTCLs) represent a group of hematopoietic malignancies that home to the ...
© 2020 Larissa DoughtyAs our understanding of the molecular changes that trigger and potentiate canc...
Contains fulltext : 57476.pdf (publisher's version ) (Closed access)CD37 is a leuk...
CD37 is a tetraspannin that triggers cell death and is a potential therapeutic target in cancers. In...
SummaryTetraspanins are commonly believed to act only as “molecular facilitators,” with no direct ro...
In a recent issue of Cell, Kumar and colleagues uncovered a synthetic lethal interaction between onc...
Contains fulltext : 165795.pdf (publisher's version ) (Closed access)Worldwide, B ...
CD37 is a tetraspanin expressed on malignant B cells. Recently, CD37 has gained interest as a therap...
Contains fulltext : 109748.pdf (publisher's version ) (Closed access)Signaling by ...
Signaling by the serine and threonine kinase Akt (also known as protein kinase B), a pathway that is...
Contains fulltext : 233575.pdf (Publisher’s version ) (Open Access)Radboud Univers...
The cochaperone CDC37 promotes recruitment of a subset of client proteins, predominantly protein kin...
CD37 (tetraspanin TSPAN26) is a B-cell surface antigen widely expressed on mature B cells. CD37 is i...
Tetraspanin CD37 has recently received renewed interest as a therapeutic target for B-cell malignanc...
Tetraspanin CD37 has recently received renewed interest as a therapeutic target for B-cell malignanc...
Cutaneous T-cell lymphomas (CTCLs) represent a group of hematopoietic malignancies that home to the ...
© 2020 Larissa DoughtyAs our understanding of the molecular changes that trigger and potentiate canc...
Contains fulltext : 57476.pdf (publisher's version ) (Closed access)CD37 is a leuk...
CD37 is a tetraspannin that triggers cell death and is a potential therapeutic target in cancers. In...
SummaryTetraspanins are commonly believed to act only as “molecular facilitators,” with no direct ro...
In a recent issue of Cell, Kumar and colleagues uncovered a synthetic lethal interaction between onc...
Contains fulltext : 165795.pdf (publisher's version ) (Closed access)Worldwide, B ...
CD37 is a tetraspanin expressed on malignant B cells. Recently, CD37 has gained interest as a therap...
Contains fulltext : 109748.pdf (publisher's version ) (Closed access)Signaling by ...
Signaling by the serine and threonine kinase Akt (also known as protein kinase B), a pathway that is...
Contains fulltext : 233575.pdf (Publisher’s version ) (Open Access)Radboud Univers...
The cochaperone CDC37 promotes recruitment of a subset of client proteins, predominantly protein kin...
CD37 (tetraspanin TSPAN26) is a B-cell surface antigen widely expressed on mature B cells. CD37 is i...
Tetraspanin CD37 has recently received renewed interest as a therapeutic target for B-cell malignanc...
Tetraspanin CD37 has recently received renewed interest as a therapeutic target for B-cell malignanc...
Cutaneous T-cell lymphomas (CTCLs) represent a group of hematopoietic malignancies that home to the ...
© 2020 Larissa DoughtyAs our understanding of the molecular changes that trigger and potentiate canc...
Contains fulltext : 57476.pdf (publisher's version ) (Closed access)CD37 is a leuk...